Decorin as a possible strategy for the amelioration of COVID-19.
Decorin as a possible strategy for the amelioration of COVID-19.
复制标题
DOI:
10.1016/j.mehy.2021.110612
复制
发表时间:
2021-07
影响因子:
4.7
通讯作者:
Bharani KK
中科院分区:
文献类型:
--
作者:
Allawadhi P;Singh V;Khurana I;Rawat PS;Renushe AP;Khurana A;Navik U;Allwadhi S;Kumar Karlapudi S;Banothu AK;Bharani KK
Coronavirus pandemic has emerged as an extraordinary healthcare crisis in modern times. The SARS-CoV-2 novel coronavirus has high transmission rate, is more aggressive and virulent in comparison to previously known coronaviruses. It primarily attacks the respiratory system by inducing cytokine storm that causes systemic inflammation and pulmonary fibrosis. Decorin is a pluripotent molecule belonging to a leucine rich proteoglycan group that exerts critical role in extracellular matrix (ECM) assembly and regulates cell growth, adhesion, proliferation, inflammation, and fibrogenesis. Interestingly, decorin has potent anti-inflammatory, cytokine inhibitory, and anti-fibrillogenesis effects which make it a potential drug candidate against the COVID-19 related complications especially in the context of lung fibrosis. Herein, we postulate that owing to its distinctive pharmacological actions and immunomodulatory effect, decorin can be a promising preclinical therapeutic agent for the therapy of COVID-19.
登录
查看更多内容
影响因子:
64.8
作者:
BORDER, WA;NOBLE, NA;RUOSLAHTI, E
通讯作者:
RUOSLAHTI, E
影响因子:
5.5
作者:
Khurana, Amit;Anchi, Pratibha;Godugu, Chandraiah
通讯作者:
Godugu, Chandraiah
影响因子:
4.8
作者:
Iozzo, Renato V.;Buraschi, Simone;Morrione, Andrea
通讯作者:
Morrione, Andrea
DOI:
10.1083/jcb.200901129
发表时间:
2009-05-18
期刊:
The Journal of cell biology
影响因子:
--
作者:
Goldoni S;Humphries A;Nyström A;Sattar S;Owens RT;McQuillan DJ;Ireton K;Iozzo RV
通讯作者:
Iozzo RV
影响因子:
5.8
作者:
Bahl, Neha;Stone, Glenn;Birzniece, Vita
通讯作者:
Birzniece, Vita